Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT06281067

Reassessment of myocardIAL Bridge TOwards PeRsOnalized Medicine

Led by Azienda Ospedaliero Universitaria Maggiore della Carita · Updated on 2024-07-10

500

Participants Needed

34

Research Sites

106 weeks

Total Duration

On this page

Sponsors

A

Azienda Ospedaliero Universitaria Maggiore della Carita

Lead Sponsor

U

Università degli Studi del Piemonte Orientale Amedeo Avogadro

Collaborating Sponsor

AI-Summary

What this Trial Is About

The "RIALTO-PRO" study aims to optimize the diagnostic and therapeutic algorithm for myocardial bridge (MB) patients, testing the diagnostic value of a full invasive diagnostic procedure, and, consequently, the prognostic value of a tailored approach. the study objective is to determine the diagnostic and prognostic value of a full-physiology approach strategy versus a standard approach strategy in patients with a MB. The "RIALTO PRO" study is a randomized, multicentre, prospective, open-label, superiority trial comparing a personalised versus standard management in patients with MB. Consenting and eligible patients will be randomised 1:1 to either a "full-physiology approach", consisting of a comprehensive diagnostic algorithm aimed at unmasking the main pathophysiological mechanism of myocardial ischemia and consequently a tailored treatment, or a "standard approach", consisting of angiographic evaluation of the tunnelled segment.

CONDITIONS

Official Title

Reassessment of myocardIAL Bridge TOwards PeRsOnalized Medicine

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ability to give informed consent to the study.
  • Age 18 years or older and 75 years or younger.
  • Diagnosis of myocardial bridge during coronary angiography.
  • Presence of symptoms or signs of inducible ischemia involving the affected vessel territory.
Not Eligible

You will not qualify if you...

  • Moderate to severe coronary artery disease with 50% or greater stenosis in any vessel.
  • Previous coronary artery bypass graft involving the affected vessel.
  • Severe valvular heart disease.
  • Left ventricular ejection fraction less than 40%.
  • Clinically significant right ventricular dysfunction.
  • Severe renal impairment (eGFR less than 30 ml/min/1.73 m2).
  • Severe hepatic impairment or history of cirrhosis with portal hypertension.
  • History of malignancy with life expectancy less than 1 year.
  • Previous ischemic stroke, intracranial hemorrhage, or related brain disease.
  • Pregnant or breastfeeding women.
  • Known allergy or contraindication to drugs used in coronary physiology testing (nitrates, adenosine, dobutamine, acetylcholine).

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 34 locations

1

Ospedale Generale Regionale F. Miulli

Acquaviva delle Fonti, Italy

Not Yet Recruiting

2

Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo

Alessandria, Italy

Not Yet Recruiting

3

Ospedale San Donato

Arezzo, Italy

Not Yet Recruiting

4

ASST Papa Giovanni XXIII

Bergamo, Italy

Not Yet Recruiting

5

Ospedale degli Infermi di Biella

Biella, Italy

Not Yet Recruiting

6

Policlinico S. Orsola IRCCS Azienda Ospedaliero Universitaria

Bologna, Italy

Not Yet Recruiting

7

Azienda Ospedaliera di Rilievo Nazionale Sant'Anna e San Sebastiano

Caserta, Italy

Not Yet Recruiting

8

Villa Maria Cecilia Hospital

Cotignola, Italy

Not Yet Recruiting

9

Azienda Ospedaliero Universitaria di Ferrara

Ferrara, Italy

Not Yet Recruiting

10

Azienda Ospedaliero Universitaria Careggi

Florence, Italy

Not Yet Recruiting

11

Azienda Ospedaliera Universitaria Policlinico San Martino

Genova, Italy

Not Yet Recruiting

12

Ospedale Della Misericordia

Grosseto, Italy

Not Yet Recruiting

13

Centro Cardiologico Monzino IRCCS

Milan, Italy

Not Yet Recruiting

14

IRCCS Ospedale Galeazzi

Milan, Italy

Not Yet Recruiting

15

Fondazione IRCCS San Gerardo dei Tintori

Monza, Italy

Not Yet Recruiting

16

AOU Maggiore della Carità

Novara, Italy, 28100

Actively Recruiting

17

Azienda Ospedaliero Universitaria di Parma

Parma, Italy

Not Yet Recruiting

18

Azienda Ospedaliera di Perugia

Perugia, Italy

Not Yet Recruiting

19

Azienda Ospedaliero Universitaria Pisana

Pisa, Italy

Not Yet Recruiting

20

Ospedale San Jacopo

Pistoia, Italy

Not Yet Recruiting

21

Ospedali Riuniti di Rivoli

Rivoli, Italy

Not Yet Recruiting

22

Aurelia Hospital

Roma, Italy

Not Yet Recruiting

23

Azienda Ospedaliera San Camillo-Forlanini

Roma, Italy

Not Yet Recruiting

24

Azienda Ospedaliero Universitaria Sant'Andrea

Roma, Italy

Not Yet Recruiting

25

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, Italy

Actively Recruiting

26

Ospedale Sandro Pertini

Roma, Italy

Not Yet Recruiting

27

Ospedale Santo Spirito

Roma, Italy

Not Yet Recruiting

28

Policlinico Universitario Tor Vergata Fondazione PTV

Roma, Italy

Not Yet Recruiting

29

Ospedale Civile Santissima Annunziata

Sassari, Italy

Not Yet Recruiting

30

Azienda Sanitaria Provinciale di Siracusa

Syracuse, Italy

Not Yet Recruiting

31

Azienda Ospedaliera Ordine Mauriziano

Torino, Italy

Not Yet Recruiting

32

Azienda Ospedaliero Universitaria Città Della Salute E Scienza

Torino, Italy

Not Yet Recruiting

33

Presidio Ospedaliero Sant'Andrea

Vercelli, Italy

Not Yet Recruiting

34

Azienda Ospedaliera Universitaria Integrata, Ospedale Borgo Trento

Verona, Italy

Not Yet Recruiting

Loading map...

Research Team

D

Domenico D'Amario, Prof

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here